Submit Manuscript

International Journal of Pharmacology

Year: 2005 | Volume: 1 | Issue: 4 | Page No.: 366-368
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Research Article

Different Profile of Propranolol and Amitriptyline Effects on Migraine Prophylaxis

M. Rafieian-Kopaei, J. Mehvari and H. Shirzadeh

ABSTRACT

This study was conducted to compare the prophylactic activity of propranolol and amitriptyline on frequency, duration and severity of migraine attacks. The rebound effects of these drugs were also evaluated. In a clinical study 105 patients were randomly allocated to one of three groups. The study was divided into three phases, each phase 45 days. In the first phase all patients received two tablet/day, placebo. In the second phase, group one received propranolol (40 mg, twice per day), group two amitriptyline (25 mg, twice per day) and group three continued to receive placebo. In the third phase of the study, all patients received placebo. Patients were free to have acetaminophen-codeine on migraine attacks. All patients were given diagnostic headache diaries in which to record frequency, duration and intensity of attacks. Propranolol and amitriptyline significantly reduced the frequency, duration and intensity of attacks. In contrast to propranolol group, there was a rebound effect following discontinuation of amitriptyline. It seems that propranolol has a therapeutic activity (other then a prophylactic effect) on migraine attacks, however, amitriptyline has only a prophylactic effect.
PDF References Citation

REFERENCES

  1. Lipton. R.B., W.F. Stewart and S. Diamond, 2001. Prevalence and burden of migraine in the United States: Data from the American migraine study II. Headache, 41: 646-657.
  2. Wong. T.W., K.S. Wong, T.S. Yu and R. Kay, 1995. Prevalence of migraine and other headaches in Hong Kong. Neuroepidemiology, 14: 82-91.
  3. Abduljabbar, M., A. Ogunniyi, S. Al-Balla, S. Al-Balla and A. Al-Dalaan, 1991. Prevalence of primary headaches syndrome in adults in the Qassim region of Saudi Arabia. Headache, 31: 365-371.
  4. Lipton, R.B., S. Diamond, M. Reed, M.L. Diamond and W.F. Stewart, 2001. Migraine diagnosis and treatment: Results from the American migraine study II. headache. J. Head Face Pain, 41: 638-645.
    CrossRefDirect Link
  5. Kaniecki, R., 2003. Headache assessment and management. J. Am. Med. Assoc., 289: 1430-1433.
    Direct Link
  6. Silberstein, S.D., 1997. Preventive treatment of migraine: An overview. Cephalalgia, 17: 67-72.
  7. Headache Classification Committee of International Headache Society, 1988. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia, 8: 1-96.
    PubMed
  8. Diener, H.C., 2003. Pharmacological approaches to migraine. J. Neural Transm. Suppl., 64: 35-63.
    PubMedDirect Link
  9. Fridi, S. and H. Kaube, 2003. Prophylactic therapy for migraine. Curr. Treat. Option. Neurol., 5: 431-440.
  10. Holdorfe, B., M. Sinn and G. Roth, 2002. Propranolol in migraine prophylaxis. Med. Clin., 27: 1115-1118.
  11. Spierings-Egilius, L.H., 2003. Pathogenesis of migraine attack. Clin. J. Pain, 19: 255-262.
  12. Peroutka, S.J., 1990. Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol. Clin., 8: 829-838.
  13. Pazos, A., G. Engel and J.M. Palacios, 1985. Beta-adrenergic blocking agents recognize subpopulation of serotonin receptors in brain. Brain Res., 343: 403-408.
  14. Ollat, H. and J.M. Gurruchaga, 1992. Piaquettes et migraine. Pathol. Biol., 40: 305-312.
  15. Amico, D., S. Usai, L. Grazz, A. Rigamonti, A. Solari, M. Leone and G. Bussone, 2003. Quality of life and disability in primary chronic dialy headaches. Neurol. Sci., 24: S95-S100.
    PubMedDirect Link
  16. Silberstein, S.D. and J. Saper, 1993. Migraine: Diagnosis and Treatment. In: Wolff's Headache and Other Head Pain, Dalessio, D., S.D. Silberstein (Eds.). 6th Edn., Oxford University Press, New York, pp: 96-170.

Related Articles

Leave a Comment

Your email address will not be published. Required fields are marked *